newsfilter
← Latest News
PR Newswire·

Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results

Company maintains priority focus on clinical programs to develop a novel functional cure for hepatitis B viral (HBV) infection and a potential first-of-its-kind treatment for postpartum depression (PPD) and major